GAL-201 as a Promising Amyloid-β-Targeting Small-Molecule Approach for Alzheimer's Disease Treatment: Consistent Effects on Synaptic Plasticity, Behavior and Neuroinflammation.

Int J Mol Sci · 2025 · PMC12071807 · PMID 40362405

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

almost significantlyno p-value reported

In addition, retest 2 showed an almost significantly faster escape latency for TG mice with GAL-201 treatment (AUC = 0.3 [0.08; 0.55]).

also in 555 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.